Novel Gonorrhea Treatment Acts as Live Vaccine, Prevents Reinfection

Updated October 16, 2013 This content is archived.

A new gonorrhea treatment has successfully eliminated gonococcal infection from female mice and prevented reinfection, according to research published by UB scientists from the Department of Microbiology and Immunology and UB’s Witebsky Center for Microbial Pathogenesis and Immunology.

9/20/13 Sci-News: New Vaccine Combats Gonorrhea, Prevents Reinfection
9/20/13 AZoNano: New Nanoparticle Treatment for Gonorrhea is Based on Anti-Cancer Drug
9/18/13 RedOrbit: Gonorrhea Treatment Reverses Suppression of Immunity, Circumvents Antibiotic Resistance
9/18/13 BreakThrough Digest: UB Researchers to Develop Technology for Gonorrhea Treatment
9/18/13 ScienceNewsline: UB Researchers Develop Gonorrhea Treatment Based on Anti-Cancer Therapy